Biomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.
|Articles|March 22, 2012
House Floor Next for Contentious GOP Budget Plan That Cuts Social Safety Net, Tax Rates
Advertisement
It’s on to the House floor for a deficit-slashing GOP budget plan.
That’s the next step after the House Budget Committee approved the bold but contentious blueprint by a near party-line vote late Wednesday.
Republican leaders may have a tougher time corralling the votes to pass the measure through the full House, where some tea party conservatives think it doesn’t go far enough, even though it calls for cutting $5.3 trillion from President Barack Obama’s budget over the coming decade, including sweeping cuts to federal health care programs and social programs aimed at the poor.
Read the full story:
Source: The Washington Post
Advertisement
Related to this article
Remibrutinib (Rhapsido; Novartis) is the only treatment with approved uses in both chronic spontaneous urticaria and symptomatic dermographism.
Leukemia survivors given high-risk ALL therapy had hip bone density about 90% of matched controls, without the partial normalization seen in other groups.
A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Sacral neuromodulation is still considered the gold standard for refractory overactive bladder, with tibial nerve stimulation a less invasive option.
FDA approved tucatinib maintenance for HER2-positive metastatic breast cancer following induction therapy based on the 654-patient HER2CLIMB-05 trial.
A meta-analysis found teleophthalmology satisfaction comparable to in-person eye care, but showed a gap between recommending it and reusing it.
Lean MASLD shows milder histology than overweight and obese MASLD but similar mortality and event risk, with fibrosis tied to prognosis.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know if Retatrutide Is Classified as a Biologic
2
Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble
3
Sacral Neuromodulation Still Seen as OAB Gold Standard in Review
4
FDA Approves Tucatinib Maintenance for HER2+ Metastatic Breast Cancer
5